Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal versus intramuscular naloxone for suspected opiate overdose in the prehospital setting
ACTRN12606000322538Phase 4Completed
- Sponsor
- Department of Human Services
- Start
- Aug 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of naloxone in opioid intoxication (2 arms), sponsored by Department of Human Services. Primary endpoint: Requirement for subsequent treatment with naloxone. Started Aug 2006; status: completed.
02
Drugs
naloxone
03
Conditions
opioid intoxication
Beyond the preview
Go deeper on ACTRN12606000322538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000322538.